Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1 with amino acid substitutions at positions 3 and extended half-life (2030 hours vs 10 minutes for endogenous IGF-1), enabling systemic anabolic signaling without growth hormone involvement
These are the typical subcutaneous injection sites used for self-administration
Stacking Semax with a bedtime peptide requires a split schedule, not a modified dose
One large observational study found higher risk for diabetes in younger adults with low IGF-1, but not in adults older than 65
Regulatory notice (May 2026): FDA proposed removing Tirzepatide from the 503B compounding bulks list verify current legal status before sourcing compounded versions
This blend is engineered to facilitate advanced studies into the GHRH/GHSR signaling axis, often researched for its potential impact on systemic recovery and metabolic biology
